Integrated Computer Solutions (ICS) recently announced that it served Quidel as the application developer for the next-generation molecular diagnostic system for its Savanna platform.
The goal is low-cost, point-of-care testing for a range of diseases and conditions including COVID-19, MRSA and HIV.
The Savanna project started with user experience design to create an intuitive CLIA-waived touchscreen interface and an extensible processing architecture, according to the companies. It also includes software applications and powerful, forward-looking cybersecurity for its fleet in the field.
“Supplementing our team with ICS’ skilled software engineers and designers enabled us to bring the development process in-house, resulting in a more responsive development cycle and tighter coupling with UX design,” said Johannes Kehle, VP of Savanna and managing director of Quidel Germany GmbH. “It goes without saying, this outcome couldn’t have happened at a more imperative time.”
ICS has collaborated with Quidel on other point-of-care technologies that have received FDA emergency use authorization.
